Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

McGill University

$28,000.00

Role of PGE2-induced up-regulation of TRPV1 channel in prolonged nociceptor sensitization and potentiation

EF 2019-20

Résumé
Sensitization of peripheral and central nociceptive neurons along pain transmission pathway is essential to the genesis of chronic pain. Plastic events at transcriptional and translational levels in nociceptive dorsal root ganglion (DRG) neurons (nociceptors) contribute to persistent peripheral sensitization. Our long term goal focuses on role of neuroplasticity induced by inflammatory mediators in prolonged nociceptor sensitization and potentiation. Prostaglandin E2 (PGE2), a well-known inflammatory mediator enriched in injured tissue, not only sensitizes nociceptors, but also potentiates the sensitizing effects of other pain mediators such as transient potential receptor vanilloid-1 (TRPV1) at functional level. TRPV1 is an integrator of diverse noxious stimuli and involved in chronic pain of inflammatory and neuropathic origins. However, it remains unknown whether PGE2 potentiates TRPV1 activity by stimulating its transcription and translation in DRG neurons and whether PGE2-induced TRPV1 synthesis contributes to persistent nociceptor sensitization and potentiation. Our pilot data suggest that PGE2 is involved in TRPV1 up-regulation in DRG neurons after inflammation and nerve injury. Moreover, PGE2 exposure not only prolongs pain evoked by subsequent challenge of TRPV1 agonist capsaicin, but also increases TRPV1 levels in DRG neurons. These data let us hypothesize that facilitating TRPV1 synthesis in DRG neurons is a novel mechanism underlying PGE2 prolonged nociceptor sensitization and potentiation. In this research program, we will target three specific short term goals using multidisciplinary approaches in both in vitro and in vivo models.*** Specific aim 1: Using molecular, neurochemical and morphological approaches, we will determine whether PGE2 induces TRPV1 synthesis at the gene and protein levels in DRG neurons in both in vitro and in vivo models and whether PGE2 contributes to TRPV1 up-regulation in animal models of prolonged sensitization pain, inflammatory pain and neuropathic pain. *** Specific aim 2: Using selective Cdk5 inhibitor and siRNA technique, we will determine whether cyclin dependent kinase 5 (Cdk5) signaling mediates PGE2-induced TRPV1 synthesis in in vitro and in vivo DRG neurons. *** Specific aim 3: Using electrophysiological, pharmacological and behavioral approaches, we will determine whether PGE2-induced TRPV1 synthesis is coupled to enhanced TRPV1 activity in cultured DRG neurons, whether PGE2-induced TRPV1 up-regulation contributes to prolonged sensitization pain in wild type rats and whether PGE2-prolonged sensitization pain is abolished in TRPV1 knockout rats.*** Significance: The anticipated outcome will advance our understanding of a novel mechanism governing development of chronic pain, i. e, facilitating TRPV1 synthesis in DRG neurons contributes to PGE2 potentiated TRPV1 activity and prolonged nociceptor sensitization.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
RGPIN-2017-04268
Name nom
Ma, Weiya
Department département
Psychiatry
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2019
Competition year année de concours
2017
Award amount
28000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1502
Committee name en
Biological Systems and Functions
Committee name fr
Systèmes et fonctions biologiques
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5100
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Cell biology
Research subject fr
Biologie cellulaire
Installment
inst:3 - 5
Partie
3
Nb partie
5
Application title
Role of PGE2-induced up-regulation of TRPV1 channel in prolonged nociceptor sensitization and potentiation
Keyword
NSERC
Application summary
Sensitization of peripheral and central nociceptive neurons along pain transmission pathway is essential to the genesis of chronic pain. Plastic events at transcriptional and translational levels in nociceptive dorsal root ganglion (DRG) neurons (nociceptors) contribute to persistent peripheral sensitization. Our long term goal focuses on role of neuroplasticity induced by inflammatory mediators in prolonged nociceptor sensitization and potentiation. Prostaglandin E2 (PGE2), a well-known inflammatory mediator enriched in injured tissue, not only sensitizes nociceptors, but also potentiates the sensitizing effects of other pain mediators such as transient potential receptor vanilloid-1 (TRPV1) at functional level. TRPV1 is an integrator of diverse noxious stimuli and involved in chronic pain of inflammatory and neuropathic origins. However, it remains unknown whether PGE2 potentiates TRPV1 activity by stimulating its transcription and translation in DRG neurons and whether PGE2-induced TRPV1 synthesis contributes to persistent nociceptor sensitization and potentiation. Our pilot data suggest that PGE2 is involved in TRPV1 up-regulation in DRG neurons after inflammation and nerve injury. Moreover, PGE2 exposure not only prolongs pain evoked by subsequent challenge of TRPV1 agonist capsaicin, but also increases TRPV1 levels in DRG neurons. These data let us hypothesize that facilitating TRPV1 synthesis in DRG neurons is a novel mechanism underlying PGE2 prolonged nociceptor sensitization and potentiation. In this research program, we will target three specific short term goals using multidisciplinary approaches in both in vitro and in vivo models.*** Specific aim 1: Using molecular, neurochemical and morphological approaches, we will determine whether PGE2 induces TRPV1 synthesis at the gene and protein levels in DRG neurons in both in vitro and in vivo models and whether PGE2 contributes to TRPV1 up-regulation in animal models of prolonged sensitization pain, inflammatory pain and neuropathic pain. *** Specific aim 2: Using selective Cdk5 inhibitor and siRNA technique, we will determine whether cyclin dependent kinase 5 (Cdk5) signaling mediates PGE2-induced TRPV1 synthesis in in vitro and in vivo DRG neurons. *** Specific aim 3: Using electrophysiological, pharmacological and behavioral approaches, we will determine whether PGE2-induced TRPV1 synthesis is coupled to enhanced TRPV1 activity in cultured DRG neurons, whether PGE2-induced TRPV1 up-regulation contributes to prolonged sensitization pain in wild type rats and whether PGE2-prolonged sensitization pain is abolished in TRPV1 knockout rats.*** Significance: The anticipated outcome will advance our understanding of a novel mechanism governing development of chronic pain, i. e, facilitating TRPV1 synthesis in DRG neurons contributes to PGE2 potentiated TRPV1 activity and prolonged nociceptor sensitization.